|
|
||||||||
Viewpoint |
1 Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037;
2 Department of Pharmaceutical Sciences, University of Michigan College of Pharmacy, Ann Arbor, MI 48109;
3 Department of Chemistry, New York University, NY, NY 10003
SUMMARY
Not so fast! Several things need to be considered before we conclude that Chen et al. have a dedifferentiating agent on their hands. The verification of small molecules as tissue- or cell-type dedifferentiating agents will require greatly sophisticated techniques and the identification of the direct molecular targets of said small molecules. By knowing what pitfalls to avoid, intelligent small-molecule design and testing may proceed more expediently.
Related articles in MI:
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ASPET Journals | Pharmacological Reviews | Drug Metabolism and Disposition |
| Molecular Interventions | Molecular Pharmacology | J Pharmacology and Exp Therapeutics |